Galimedix Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Strategy
    • Management Team
    • Board of Directors
  • Products
  • Technology
    • Overview
    • MOA
    • Preclinical Experiments
    • Glaucoma Preclinical Data
    • AMD Preclinical Data
    • Trigger Effect
    • Superior Approach
    • Neurorestoration
  • Clinical Trials
  • References
  • News & Media
    • Press Releases
    • Presentations
    • Posters
    • Events
    • In the News
    • Videos
  • Contact

Videos

News & Media

News & Media

  • Press Releases
  • Presentations
  • Posters
  • Events
  • In the News
  • Videos
Galimedix Therapeutics aims to stop the progression of glaucoma and dry AMD

Galimedix Therapeutics aims to stop the progression of glaucoma and dry AMD

© 2022 Galimedix Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap